RAPP
Rapport Therapeutics, Inc. · Healthcare
Chief Scientific Officer David Bredt sold $247K of Rapport Therapeutics, Inc.
Sold$246,655
$29.02Price
8,500Shares
−2%Stake
What RAPP did after the filing
- The stock from Thu, Feb 19 close, $29.99
- +12.0%
- S&P 500, same days
- −4.2%
Measured over 30 trading days, to the Apr 2 close.
Traded Tue, Feb 17. Filed Thu, Feb 19, 2:05 PM ET, during the session. Returns use the Feb 19 close and the Apr 2 close. Not investment advice.